Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study

BACKGROUND: Tumor Necrosis Factor inhibitors (TNFi) have dramatically improved the outlook for patients with inflammatory arthritides and bowel disease (IBD), but are associated with increased infection risks, including tuberculosis (TB). Pediatric inflammatory diseases are uncommon, and the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoll, Matthew L., Grubbs, James Aaron, Beukelman, Timothy, Mannion, Melissa L., Jester, Traci W., Cron, Randy Q., Crain, Marilyn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679346/
https://www.ncbi.nlm.nih.gov/pubmed/29121953
http://dx.doi.org/10.1186/s12969-017-0207-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679346/
https://www.ncbi.nlm.nih.gov/pubmed/29121953
http://dx.doi.org/10.1186/s12969-017-0207-8

Ejemplares similares